Next Article in Journal
Approach to Thromboprophylaxis for Prevention of Venous Thromboembolism in COVID-19: Global Updates and Clinical Insights from India
Previous Article in Journal
Glomangioma Supply from Profunda Femoris Artery in Peripheral Artery Disease
 
 
Communication

Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices

1
Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
2
Division of Medical Ethics, School of Medicine, New York University, 227 East 30th Street, New York, NY 10016, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Myeong Soo Lee
Clin. Pract. 2022, 12(5), 760-765; https://doi.org/10.3390/clinpract12050079
Received: 11 August 2022 / Revised: 9 September 2022 / Accepted: 19 September 2022 / Published: 22 September 2022
End-of-life decision making is a troublesome ethical dilemma. These decisions should be made in trustful patient–doctor relationships. We aimed to propose a balanced approach when discussing this complex issue. We categorized the research into four approaches and suggest that a multidisciplinary approach may be appropriate. We also analyzed the pitfalls of the multidisciplinary approach. Our conclusion is two-fold. First, discussions in this field should be based on real-world practice. If this is not the case, the proposal may be armchair theory, which is not effective in a clinical setting. Second, interdisciplinary researchers should not stick to their position too firmly and should listen to others. Otherwise, proposals made will be paternalistic or philosophically biased. Therefore, when philosophical collaboration is applied to the topic of clinical bioethics, it is necessary to thoroughly examine different positions and carry out careful discussions with consideration for medical care settings. Researchers must also understand what is needed for a trustful patient–doctor relationship. By making such efforts, clinical bioethics will contribute to the wellbeing of patients. View Full-Text
Keywords: decision-making capacity; patient–doctor relationship; clinical ethics; end of life; trust decision-making capacity; patient–doctor relationship; clinical ethics; end of life; trust
MDPI and ACS Style

Akabayashi, A.; Nakazawa, E.; Ino, H. Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices. Clin. Pract. 2022, 12, 760-765. https://doi.org/10.3390/clinpract12050079

AMA Style

Akabayashi A, Nakazawa E, Ino H. Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices. Clinics and Practice. 2022; 12(5):760-765. https://doi.org/10.3390/clinpract12050079

Chicago/Turabian Style

Akabayashi, Akira, Eisuke Nakazawa, and Hiroyasu Ino. 2022. "Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices" Clinics and Practice 12, no. 5: 760-765. https://doi.org/10.3390/clinpract12050079

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop